Group One Trading
MRVI icon

Group One Trading’s Maravai LifeSciences MRVI Stock Holding History

Group One Trading’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,653
Closed -$41.7K – 8158
2026
Q1 		$27.3K Buy
+9,653
New +$32.7K ﹤0.01% 5746
2025
Q2 		– Sell
-15,813
Closed -$33.2K – 8382
2025
Q1 		$34.9K Buy
+15,813
New +$62.5K ﹤0.01% 5439
2024
Q4 		– Sell
-21,727
Closed -$140K – 7707
2024
Q3 		$181K Buy
+21,727
New +$188K ﹤0.01% 3710
2024
Q2 		– Sell
-7,723
Closed -$66.7K – 7197
2024
Q1 		$67K Buy
7,723
+664
+9% +$4.49K ﹤0.01% 4467
2023
Q4 		$46.2K Sell
7,059
-20,388
-74% -$132K ﹤0.01% 5121
2023
Q3 		$274K Sell
27,447
-127,250
-82% -$1.4M ﹤0.01% 3520
2023
Q2 		$1.92M Buy
154,697
+142,634
+1,182% +$1.93M 0.01% 1744
2023
Q1 		$169K Buy
12,063
+4,735
+65% +$68K ﹤0.01% 3816
2022
Q4 		$105K Buy
7,328
+4,097
+127% +$64.5K ﹤0.01% 4402
2022
Q3 		$82K Sell
3,231
-8,525
-73% -$214K ﹤0.01% 4956
2022
Q2 		$334K Buy
+11,756
New +$372K ﹤0.01% 3810

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Group One Trading's MRVI Position: Q2 2026 in Review

Group One Trading sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 9,653 shares — an estimated $41.7K sold.

Group One Trading first reported a position in MRVI in Q2 2022 and held it in 11 quarters. The position peaked at $1.92M in Q2 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Group One Trading reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 9,653 Maravai LifeSciences shares in Q2 2026, an estimated $41.7K.
  • Group One Trading first reported a position in Maravai LifeSciences in Q2 2022 and held it in 11 quarters.
  • Group One Trading's Maravai LifeSciences position peaked at $1.92M in Q2 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.